NRG Oncology adds new leadership members to Developmental Therapeutics, Patient Centered Outcomes Research, Protocol Operations Management, Head and Neck Cancer, and Translational Science committees - EurekAlert!
FDA approves immune checkpoint inhibitor drug for patients with resectable locally advanced head and neck cancer, backed by Dana-Farber research - EurekAlert!
Immunotherapy improves survival of patients with locally advanced head and neck cancer: « Approved drug that revolutionized melanoma treatment may change standard of care for yet another cancer type. »
New guidelines for radiation therapy for HPV-associated head and neck cancer - EurekAlert
